Gaspari et al. documented a GLP-1R-dependent inhibition of endothelial dysfunction by liraglutide in the ApoE-/- mouse model through increasing eNOS expression and suppressing ICAM-1 expression in the aortic endothelium [13]. The gene discussed is ICAM1; the disease is endothelial dysfunction.